China’s Infervision, which uses AI to detect cancer cells through image analysis, has expanded the use of its platform to more than 280 hospitals globally and is adding around 12 partner institutions per week. Infervision uses a deep learning algorithm powered by similar technology to that found in facial recognition and autonomous driving. Initially focusing on lung cancer detection, the company now plans to expand its platform to other chest-related health conditions, such as cardiac calcification. To date, the company has raised $70 millionm in investment.
China’s Infervision, which uses AI to detect cancer cells through image analysis, has expanded the use of its platform to more than 280 hospitals globally and is adding around 12 partner institutions per week. Infervision uses a deep learning algorithm powered by similar technology to that found in facial recognition and autonomous driving. Initially focusing on lung cancer detection, the company now plans to expand its platform to other chest-related health conditions, such as cardiac calcification. To date, the company has raised more than $70m in investment.